We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
-17.96%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$10B
AUM Growth
-$4.54B
Cap. Flow
-$1.63B
Cap. Flow %
-16.3%
Top 10 Hldgs %
18.24%
Holding
2,308
New
654
Increased
395
Reduced
491
Closed
723

Top Sells

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$173M
2
EBAY icon
eBay
EBAY
+$149M
3
ZTS icon
Zoetis
ZTS
+$127M
4
TFX icon
Teleflex
TFX
+$108M
5
TMO icon
Thermo Fisher Scientific
TMO
+$98.9M

Sector Composition

Rank Sector Weight
1 Healthcare 23.96%
2 Consumer Discretionary 18.46%
3 Technology 13.47%
4 Financials 11.57%
5 Industrials 7.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PFE icon
151
Pfizer
PFE
$140B
$14.7M 0.15%
474,348
-2,895,323
-86% -$98.7M
HCA icon
152
HCA Healthcare
HCA
$84.8B
$14.7M 0.15%
163,294
-188,402
-54% -$24.4M
UNP icon
153
Union Pacific
UNP
$183B
$14.7M 0.15%
+104,015
New +$17.2M
AIG icon
154
American International
AIG
$41.9B
$14.5M 0.15%
599,924
+43,234
+8% +$1.85M
LOW icon
155
Lowe's Companies
LOW
$116B
$14.3M 0.14%
165,822
-218,696
-57% -$23.9M
PBR icon
156
Petrobras
PBR
$121B
$14.2M 0.14%
2,577,556
+2,546,816
+8,285% +$30.4M
RY icon
157
Royal Bank of Canada
RY
$291B
$14.1M 0.14%
+230,219
New +$17.1M
HYG icon
158
CALL
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.3B
$14.1M 0.14%
179,100
+98,200
+121% +$8.3M
NATI
159
DELISTED
National Instruments Corp
NATI
$14M 0.14%
422,499
+148,292
+54% +$5.93M
FICO icon
160
Fair Isaac
FICO
$28.7B
$13.9M 0.14%
45,247
+13,692
+43% +$5.04M
LH icon
161
Labcorp
LH
$24.3B
$13.8M 0.14%
127,329
+82,665
+185% +$11.9M
IT icon
162
Gartner
IT
$9.41B
$13.7M 0.14%
+137,712
New +$18.9M
DB icon
163
Deutsche Bank
DB
$66.3B
$13.2M 0.13%
+2,019,915
New +$16.8M
BBY icon
164
Best Buy
BBY
$18B
$13.2M 0.13%
231,827
+231,735
+251,886% +$18.4M
GO icon
165
Grocery Outlet
GO
$891M
$13.1M 0.13%
380,846
+354,572
+1,350% +$11.5M
HBI
166
DELISTED
Hanesbrands
HBI
$13.1M 0.13%
1,661,661
-164,227
-9% -$2.08M
ENTA icon
167
Enanta Pharmaceuticals
ENTA
$372M
$13M 0.13%
251,961
+70,906
+39% +$3.78M
NYT icon
168
New York Times
NYT
$11.6B
$12.9M 0.13%
421,121
-144,599
-26% -$4.97M
URI icon
169
United Rentals
URI
$71.1B
$12.9M 0.13%
125,378
+108,193
+630% +$14.3M
COLD icon
170
Americold
COLD
$4.09B
$12.9M 0.13%
377,698
+211,777
+128% +$7.09M
NVR icon
171
NVR
NVR
$17.2B
$12.8M 0.13%
4,977
+4,596
+1,206% +$16.5M
RRX icon
172
Regal Rexnord
RRX
$14.2B
$12.6M 0.13%
199,481
+26,944
+16% +$2.11M
GD icon
173
General Dynamics
GD
$105B
$12.4M 0.12%
93,817
+65,218
+228% +$10.8M
VZ icon
174
Verizon
VZ
$194B
$12.4M 0.12%
230,001
-381,822
-62% -$21.8M
BPMC
175
DELISTED
Blueprint Medicines
BPMC
$12.3M 0.12%
211,006
+204,103
+2,957% +$13.1M

Similar funds

Marshall Wace's Q1 2020 Portfolio in Review

As of Q1 2020, Marshall Wace held 2,308 positions worth $10B, down 31% from $14.5B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Marshall Wace withdrew a net $1.63B in Q1 2020, closing 723 positions and reducing 491 holdings. Its most notable exit was eBay, an estimated $149M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, Marshall Wace opened a new position in Bank of Montreal worth $53.5M.

  • Marshall Wace's largest Q1 2020 buy was Bank of Montreal: 1,072,183 shares worth $53.5M.
  • Marshall Wace added most to Fidelity National Information Services in Q1 2020, an estimated $146M increase.
  • Marshall Wace's biggest Q1 2020 reduction was Boston Scientific, cutting an estimated $173M.
  • Marshall Wace fully exited eBay in Q1 2020, selling an estimated $149M.
  • Marshall Wace's ten largest holdings make up 18% of its $10B portfolio in Q1 2020.
  • Marshall Wace opened 654 new positions and closed 723 in Q1 2020.
  • Marshall Wace's portfolio value fell 31% quarter-over-quarter to $10B.

Based on Marshall Wace's 13F filing for Q1 2020, filed 15 May 2020.